The future of TAM-targeted therapies is promising but requires further research. Combining TAM-targeted therapies with other treatments, such as chemotherapy, radiation, or immunotherapy, may enhance their efficacy. Personalized medicine approaches that consider the specific characteristics of a patient's tumor and its microenvironment are also likely to improve outcomes. Ongoing clinical trials are exploring various strategies to modulate TAMs, and initial results are encouraging.
